Cite
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody–associated vasculitis.
MLA
Sada, Ken-ei, et al. “Validation of New ACR/EULAR 2022 Classification Criteria for Anti-Neutrophil Cytoplasmic Antibody–associated Vasculitis.” Modern Rheumatology, vol. 34, no. 1, Jan. 2024, pp. 144–50. EBSCOhost, https://doi.org/10.1093/mr/road017.
APA
Sada, K., Kaname, S., Higuchi, T., Furuta, S., Nagasaka, K., Nanki, T., Tsuboi, N., Amano, K., Dobashi, H., Hiromura, K., Bando, M., Wada, T., Arimura, Y., Makino, H., & Harigai, M. (2024). Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody–associated vasculitis. Modern Rheumatology, 34(1), 144–150. https://doi.org/10.1093/mr/road017
Chicago
Sada, Ken-ei, Shinya Kaname, Tomoaki Higuchi, Shunsuke Furuta, Kenji Nagasaka, Toshihiro Nanki, Naotake Tsuboi, et al. 2024. “Validation of New ACR/EULAR 2022 Classification Criteria for Anti-Neutrophil Cytoplasmic Antibody–associated Vasculitis.” Modern Rheumatology 34 (1): 144–50. doi:10.1093/mr/road017.